P
Ping Zhang
Researcher at Centers for Disease Control and Prevention
Publications - 166
Citations - 12698
Ping Zhang is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 45, co-authored 150 publications receiving 10596 citations. Previous affiliations of Ping Zhang include Commonwealth Scientific and Industrial Research Organisation & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Erratum to ''Global healthcare expenditure on diabetes for 2010 and 2030'' (Diabetes Res. Clin. Pract. 87 (1) (2010) 293-301)
Ping Zhang,Xinzhi Zhang,Jonathan B. Brown,Dorte Vistisen,Richard Sicree,Jonathan E. Shaw,Gregory A. Nichols +6 more
TL;DR: This poster presents a probabilistic procedure to quantify the importance of baseline insulin resistance in patients with type 2 diabetes and reports the results indicate thatrelapse is a more accurate predictor of disease than prior studies.
Journal ArticleDOI
Factors Contributing to Increases in Diabetes-Related Preventable Hospitalization Costs Among U.S. Adults During 2001-2014
TL;DR: The total cost of diabetes-related preventable hospitalizations had been increasing during 2001–2014, mainly resulting from increases in number of people with diabetes and cost per hospitalization day, and could lead to efforts that may lower future hospitalization costs.
Journal ArticleDOI
Depth variations of 410 km and 660 km discontinuities in eastern North China Craton revealed by ambient noise interferometry
TL;DR: In this article, the retrieved P410P and P660P phases from stacked correlations reveal lateral variations of both depths and sharpness of the 410-km and 660-km discontinuities along two profiles, which may be related with hot material upwelling and the effect of stagnant Pacific plate in the transition zone beneath North China Craton.
Journal ArticleDOI
State-level diabetes-attributable mortality and years of life lost in the United States.
TL;DR: Mortality attributable to diabetes is greatly underestimated when looking only at diabetes listed as an underlying cause of death, and these results can be used to track state differences in deaths due to diabetes and to monitor the success of public health activities.
Journal ArticleDOI
Cost-effectiveness of alternative thresholds of the fasting plasma glucose test to identify the target population for type 2 diabetes prevention in adults aged ≥45 years
TL;DR: Lowering the FPG threshold leads to a greater health benefit of diabetes prevention but reduces the cost-effectiveness, which is in line with the conventional benchmark.